GET THE APP

Synthesis, characterization and biological activities of some new acidhydrazones derived from 2-[(N-cinnamoyl) 2, 5-dichloroanilido] acetohydrazide | Abstract
Scholars Research Library

Scholars Research Library

A-Z Journals

+44 7389645282

Der Pharmacia Lettre

Abstract

Synthesis, characterization and biological activities of some new acidhydrazones derived from 2-[(N-cinnamoyl) 2, 5-dichloroanilido] acetohydrazide

Author(s): Raj Narayan Sharma

A series of new acid hydrazones have been synthesized by the reaction of 2-[(N-cinnamoyl) 2, 5- dichloroanilido] acetohydrazide with various Carbonyl Compounds in 42 to 88 % yield. Hydrazones are white, brown and yellow colour solids, having high melting points. Newly synthesized compounds (1, 2, 3, 4, 5, 6, 7, 8, 9, 12, 13, 14, 15, 16 and 17) have been tested for their antibacterial activity against gram positive bacteria S.albus, S.aureus and gram negative bacteria E.Coli and Pseudomonas piosineus .The compound 2, 3, 5, 12, 13, 14, and 15 shown significant activity and compound 1, 4, 6, 7, 8, 9, 16 and 17 have shown moderate activity. The same compounds were tested for their antifungal activity against Candida albicans, Aspergillus Niger and Alternaria alternata at concentration of 30 mg/mL using savored dextrose agar media. The compound 2, 5, 12, 13, 14, and 15 shown significant activities and compound 1, 4, 8, 9, 16 and 17 have shown moderate activity against Candida albicans and Aspergillus Niger. All the other compounds did not show significant activity against the fungi at the concentration used. Some new compounds have been tested for antitubercular activity in-vitro using Mycobacterium tuberculosis. The compounds were incorporated into Lowenstein Jensen egg medium having concentrations of 10 and 100 mg/mL and were inoculated with Mycobacterium tuberculosis, H27, Rv strains, incubated at 370C and observed, the compound 1, 3, 4, 14 inhibited the growth of Mycobacterium tuberculosis at 100mg/mL concentration other compounds were found to be inactive.